Sharing Knowledge in Smallcaps

[timhyma]

LCAV
Picked this up last week. Should move on volume. Any thoughts?
Bought it at .70, target is $1.04

LCA Vision, Inc. operates 34 laser vision correction centers, 32 of which are located in metropolitan markets throughout the United States, one of which is in Canada and one of which is in Europe. Its centers are supported by credentialed ophthalmologists and optometrists. The ophthalmologists perform the laser vision correction procedures, and either ophthalmologists or optometrists carry out the pre-procedure evaluations and post-procedure follow-ups. The Company has performed laser vision correction procedures since 1991, and nearly all procedures are now LASIK

For the nine months ended 9/30/01, total revenues increased 17% to $57.2 million. Net loss rose from $807 thousand to $18.7 million. Revenues reflect an increase in the number of laser vision correction procedures performed. Higher loss reflects restructuring charges and a $15.3 million valuation reserve for deferred tax assets.

Recent Price $0.66
Book Value (mrq) $0.93
Total Cash (mrq) $20.1M
Shares Outstanding 46.0M Float 29.9M
Shares Short 59.0K
Insider and 5%+ Owners: 35%
Net Inst. Buying: 111.0K shares (+2.41%)
Of the 46.0 million of shares outstanding, 8.35 million are owned by insiders so insider holdings account for 18.1% of the company stock

LCA-Vision Inc., a micro-cap value company in the health care sector, is expected to significantly underperform the market over the next six months with above average risk
The price-to-sales multiple is slightly lower than the average for all stocks in the StockScouter universe. Positive for a small company like LCAV
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The price-to-earnings multiple is a negative number. No effect
The StockScouter measure of relative price change and consistency is very low. Very negative
Over the next 1-2 months, StockScouter forecasts that value stocks will be neutral, micro-cap stocks will be neutral, and health care stocks will be neutral.
LCAV's business is in the healthy fiscal bliss known as "cash flow positive heaven".


Support Price (5day): $0.660 Support Price (20day): $0.660 Support Price (50day): $0.620 Support Price (100day): $0.620

Resistance Price (5day): $0.740 Resistance Price (20day): $0.940 Resistance Price (50day): $0.950 Resistance Price (100day): $2.420
Composite Indicator TrendSpotter (TM) Sell